DONALD ALLEN: Open Payments
NPI 1942224050 · COALVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 7 companies in 2025. Trend: 2023 $185 · 2024 $470 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| Novo Nordisk Inc | 1 | $25 |
| Corcept Therapeutics | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: VRAYLAR, Ozempic, Korlym, ZORYVE, Cologuard Collection Kit, SHINGRIX, VOQUEZNA.
Industry payments across UT — which companies pay providers there.
